gfh925
Showing 1 - 2 of 2
Advance NSCLC Trial (GFH925, Cetuximab)
Not yet recruiting
- Advance Non-small Cell Lung Cancer
- GFH925
- Cetuximab
- (no location specified)
Mar 7, 2023
KRAS G12C Trial in Guangzhou (GFH925)
Recruiting
- KRAS G12C
- GFH925
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Aug 1, 2022